Ed Keystone
Impact in
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Genetics top 5%
- Genetic Associations and Epidemiology
- Inflammatory Bowel Disease
Papers in
- Rheumatology 24
- Rheumatoid Arthritis Research and Therapies 24
-
- Multiple Myeloma Research and Treatments 1
- Co-authors
- Carl F. Ware (1 shared paper)Bindee Kuriya (3 shared papers)Josef S Smolen (2 shared papers)Paul E. Emery (4 shared papers)Désirée M F M van der Heijde (2 shared papers)Mohan V. Bala (1 shared paper)Joachim Robert Kalden (1 shared paper)Daniel Baker (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (5 papers)Lara D. Veeken (4 papers)The American Journal of the Medical Sciences (1 paper)Clinical Rheumatology (1 paper)ACR Open Rheumatology (1 paper)
- Partner nations
- CanadaUnited StatesAustria
In The Last Decade
Ed Keystone
24 papers receiving 2.4k citations
Ed Keystone's Hit Papers
Peers
Comparison fields: 5 of 101
- Rheumatology 1.2k
- Genetics 703
- Immunology 164
- Biological Psychiatry 10
- Molecular Biology 355
Countries citing papers authored by Ed Keystone
This map shows the geographic impact of Ed Keystone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Keystone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Keystone more than expected).
Fields of papers citing papers by Ed Keystone
This network shows the impact of papers produced by Ed Keystone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Keystone. The network helps show where Ed Keystone may publish in the future.
Co-authors
The 25 scholars most cited alongside Ed Keystone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetics of rheumatoid arthritis contributes to biology and drug discovery Hit paper breakdown → | 2013 | 1837 |
| 2 | 2008 | 204 | |
| 3 | 2005 | 105 | |
| 4 | Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. | 2004 | 67 |
| 5 | 2010 | 60 | |
| 6 | 2017 | 46 | |
| 7 | 2015 | 36 | |
| 8 | 2016 | 31 | |
| 9 | 2013 | 18 | |
| 10 | 2008 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2009 | 12 | |
| 13 | 24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 2012 | 12 |
| 14 | 2014 | 10 | |
| 15 | 2019 | 10 | |
| 16 | Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 2012 | 9 |
| 17 | 12-and 24-Week Patient-Reported Outcomes From a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis | 2012 | 7 |
| 18 | 2012 | 6 | |
| 19 | Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose | 2004 | 5 |
| 20 | 2012 | 4 |
About Ed Keystone
Ed Keystone is a scholar working on Rheumatology, Hematology, Radiology, Nuclear Medicine and Imaging, Physiology and Genetics, having authored 25 papers that have together received 2.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (24 papers), Genetic Associations and Epidemiology (1 paper), Clinical Laboratory Practices and Quality Control (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Rheumatology (1.2k citations), Genetics (703 citations), Immunology (164 citations), Biological Psychiatry (10 citations) and Molecular Biology (355 citations). Ed Keystone has collaborated with scholars based in Canada, United States and Austria. Frequent co-authors include Carl F. Ware, Bindee Kuriya, Josef S Smolen, Paul E. Emery, Désirée M F M van der Heijde, Mohan V. Bala, Joachim Robert Kalden, Daniel Baker, Ravinder Nath Maini and Daniel Aletaha. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, The American Journal of the Medical Sciences, Clinical Rheumatology and ACR Open Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.